The Latest Breaking News from Cervical Cancer

HPV vaccines have been authorised in the European Union since 2006.

A new study suggests a single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer

Cervical cancer is the fourth most common cancer in women worldwide and causes more than 300,000 deaths each year

Studies show girls vaccinated by age 16 face dramatically lower cervical cancer risk with no major side effects.

Researchers have found that human papillomavirus (HPV) vaccines are highly effective at reducing cervical cancer-causing infections and can offer herd immunity, reinforcing previous research and highlighting the need for a global HPV vaccine rollout.

Misinformation plagued the first rollout of a vaccine to protect Pakistani girls against cervical cancer, with parents slamming their doors on healthcare workers and some schools shutting for days over false claims it causes infertility.

Pakistan's health minister says the country has vaccinated about 9 million adolescent girls against the virus that causes cervical cancer, as part of a continuing national campaign that has overcome early setbacks fueled by skeptics online

Designed with user accessibility in mindhe app offers voice input, offline access, and will provide guidance to nearby screening facilities once the maps are added.

Despite vaccination hesitancy, the end may be in sight for cervical cancer, which kills 64% of women with the disease

Few viruses are as widespread – and sometimes misunderstood – as the human papillomavirus, or HPV. It’s so common that most of us – up to 80% – will encounter it at some point in our lives, often without even realising it. Understanding HPV matters, given that it is linked…

IN FULL